Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer

Clinical trial NCT05954078 · RECRUITING

Trial details

NCT number: NCT05954078
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

High-risk Stage II Colorectal Cancer Stage III Colorectal Cancer Circulating Tumor DNA Methylation

Start date: 2023-08-01
Primary completion: 2026-06-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.